How dietary deficiency, genes and a toxin can cooperate to produce arteriosclerosis and ischemic heart disease

Cellular and Molecular Biology

Volumn 52, Issue 5, 2006, Pages 11-15

  Klevay, L M ^a  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Collagen; Copper; Deficiency; Elastin; Folate; Four ways of becoming ill; Homocysteine; Lysyl oxidase; Methionine synthase; Paraoxonase; Superoxide dismutase

Indexed keywords

ARYLDIALKYLPHOSPHATASE; ARYLDIALKYLPHOSPHATASE 1; COLLAGEN; ELASTIN; FOLIC ACID; HOMOCYSTEINE; HOMOCYSTEINE THIOLACTONE; METHIONINE SYNTHASE; PROTEIN LYSINE 6 OXIDASE; SUPEROXIDE DISMUTASE;

ABDOMINAL AORTA ANEURYSM; ARTERIOSCLEROSIS; ARTICLE; COPPER DEFICIENCY; CROSS LINKING; DIET; DISEASE CLASSIFICATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENETIC DISORDER; HUMAN; HYPERHOMOCYSTEINEMIA; ISCHEMIC HEART DISEASE; NONHUMAN; NUTRITIONAL DEFICIENCY; OSTEOPOROSIS;

ANIMALS; ARTERIOSCLEROSIS; ARYLDIALKYLPHOSPHATASE; COLLAGEN; COPPER; DIET; ELASTIN; HEART DISEASES; HOMOCYSTEINE; HUMANS; MALNUTRITION; MYOCARDIAL ISCHEMIA;

EID: 34247557612     PISSN: 01455680     EISSN: 1165158X     Source Type: Journal    
DOI: 10.1170/T728     Document Type: Article

References (40)

1. Allen, K.G. and Klevay, L.M., Copper: an antioxidant nutrient for cardiovascular health. Curr. Opin. Lipidol. 1994, 5:22-28.
2. Anon., Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. Homocysteine Lowering Trialists' Collaboration. Br.Med.J.Clin.Res.Ed. 1998, 316:894-898.
3. Anon., Copper. In: Dietary reference intakes for vitamin A. vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zincNational Academy of Sciences, Washington, D.C., 2001, pp. 7-1 to 7-27
4. Bogden, J.D., Oleske, J.M., Munves, E.M., Lavenhar, M.A., Bruening, K.S., Kemp, F.W., Holding, K.J., Denny, T.N. and Louria, D.B., Zinc and immunocompetence in the elderly: baseline data on zinc nutriture and immunity in unsupplemented subjects. Am. J. Clin. Nutr. 1987, 46:101-109.
5. Brown, J.C. and Strain, J.J., Effect of dietary homocysteine on copper status in rats. J.Nutr. 1990, 120:1068-1074.
6. Brunelli, T., Prisco, D., Fedi, S., Rogolino, A., Farsi, A., Marcucci, R., Giusti, B., Pratesi, C., Pulli, R., Gensini, G.F., Abbate, R. and Pepe, G., High prevalence of mild hyperhomocysteinemia in patients with abdominal aortic aneurysm. J. Vasc. Surg. 2000, 32:531-536.
7. Dubick, M.A., Keen, C.L., DiSilvestro, R.A., Eskelson, C.D., Ireton, J. and Hunter, G.C., Antioxidant enzyme activity in human abdominal aortic aneurysmal and occlusive disease. Proc.Soc.Exp.Biol.Med. 1999, 220:39-45.
8. Eckerson, H.W., Wyte, C.M. and La Du, B.N., The human serum paraoxonase/arylesterase polymorphism. Am. J. Hum..Genet. 1983, 35:1126-1138.
9. Finkelstein, J.D., Regulation of homocysteine metabolism. In: Homocysteine in health and disease,Carmel, R., Jacobsen, D.W. ed.University Press, Cambridge, 2001, pp. 92-99
10. Harker, L.A., Ross, R., Slichter, S.J. and Scott, C.R., Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. J. Clin. Invest. 1976, 58:731-741.
11. Jakubowski, H., Calcium-dependent human serum homocysteine thiolactone hydrolase. A protective mechanism against protein N-homocysteinylation. J. Biol. Chem. 2000, 275:3957-3962.
12. Klevay, L.M., Elements of ischemic heart disease. Perspect.Biol.Med. 1977, 20:186-192.
13. Klevay, L.M., Magnesium, calcium, copper, and zinc in meals. Correlations related to the epidemiology of ischemic heart disease. Biol.Trace Elem.Res. 1982, 4:95-104.
14. Klevay, L.M., Dietary cholesterol lowers liver copper in rabbits. Biol.Trace Elem.Res. 1988, 16:51-57.
15. Klevay, L.M., Four ways of becoming ill. Med.Hypotheses. 1988, 27:65-70.
16. Klevay, L.M., Lack of a recommended dietary allowance for copper may be hazardous to your health. J.Am.Coll.Nutr. 1998, 17:322-326.
17. Klevay, L.M., Trace element and mineral nutrition in disease: Ischemic heart disease. In: Clinical nutrition of the essential trace elements and minerals: The guide for health professionals,Bogden, J.D. and Klevay, L.M. eds.Humana Press Inc., Totowa, NJ, 2000, pp. 251-271
18. Klevay, L.M., Advances in cardiovascular-copper research. In: Trace elements in nutrition, health and disease,Schrauzer, G.N. ed.Institut Rosell, Montreal, Canada, 2002, pp. 64-71
19. Klevay, L.M., Ischemic heart disease as deficiency disease. Cell. Mol. Biol. (Noisy-le-grand). 2004, 50:877-884.
20. Klevay, L.M., Copper. In: Encyclopedia of Dietary Supplements, Coates, P., Blackman,M.R., Cragg, G., Levine,M., Moss, J., White, J. ed.Marcel Dekker, Inc., New York, 2005, pp. 133-141
21. Lamb, D.J., Tickner, M.L., Hourani, S.M. and Ferns, G.A., Dietary copper supplements modulate aortic superoxide dismutase, nitric oxide and atherosclerosis. Int. J. Exp. Pathol. 2005, 86:247-255.
22. Liu, G., Nellaiappan, K. and Kagan, H.M., Irreversible inhibition of lysyl oxidase by homocysteine thiolactone and its selenium and oxygen analogues. Implications for homocystinuria. J. Biol. Chem. 1997, 272:32370-32377.
23. Mackness, M.I., Durrington, P.N. and Mackness, B., The role of paraoxonase 1 activity in cardiovascular disease: potential for therapeutic intervention. Am. J. Cardiovasc. Drugs. 2004, 4:211-217.
24. McCully, K.S., Homocysteine, vitamins, and prevention of vascular disease. Mil. Med. 2004, 169:325-329.
25. McCully, K.S. and Ragsdale, B.D., Production of arteriosclerosis by homocysteinemia. Am.J.Pathol. 1970, 61:1-11.
26. McCully, K.S. and Wilson, R.B., Homocysteine theory of arteriosclerosis. Atherosclerosis. 1975, 22:215-227.
27. McLean, R.R., Jacques, P.F., Selhub, J., Tucker, K.L., Samelson, E.J., Broe, K.E., Hannan, M.T., Cupples, L.A. and Kiel, D.P., Homocysteine as a predictive factor for hip fracture in older persons. N .Engl .J. Med. 2004, 350:2042-2049.
28. O'Dell, B.L., Copper. In: Present knowledge in nutrition,Brown, M.L. ed.International Life Sciences Institute-Nutrition Foundation, Washington, D.C., 1990, pp. 261-267
29. Owen, C.A., Jr., Copper deficiency and toxicity. Noyes Publications, Park Ridge, N.J., 1981, pp. 8-9
30. Pang, Y., MacIntosh, D.L. and Ryan, P.B., A longitudinal investigation of aggregate oral intake of copper. J. Nutr. 2001, 131:2171-2176.
31. Phuntuwate, W., Suthisisang, C., Koanantakul, B., Mackness, M.I. and Mackness, B., Paraoxonase 1 status in the Thai population. J. Hum. Genet. 2005, 50:293-300.
32. Posner, B.M., Cobb, J.L., Belanger, A.J., Cupples, L.A., D'Agostino, R.B. and Stokes, J., Dietary lipid predictors of coronary heart disease in men. The Framingham Study. Arch.Intern.Med. 1991, 151:1181-1187.
33. Rainwater, D.L., Mahaney, M.C., Wang, X.L., Rogers, J., Cox, L.A. and Vandeberg, J.L., Determinants of variation in serum paraoxonase enzyme activity in baboons. J. Lipid Res. 2005, 46:1450-1456.
34. Roest, M., Jansen, A.C., Barendrecht, A., Leus, F.R., Kastelein, J.J. and Voorbij, H.A., Variation at the paraoxonase gene locus contributes to carotid arterial wall thickness in subjects with familial hypercholesterolemia. Clin.Biochem. 2005, 38:123-127.
35. Sansonetti, P.J., Introduction to the diversiy of bacterial pathogens. In: Oxford Textbook of Medicine,Weatherall, D.J., Ledingham, J.G. and Warrell, D.A. eds.Oxford University Press, Oxford, 1996, pp. 268-272
36. Su, S.Y., Chen, J.H., Huang, J.F., Wang, X.L., Zhao, J.G., Shen, Y., Qiang, B.Q. and Gu, D.F., Paraoxonase gene cluster variations associated with coronary heart disease in Chinese Han women. Chin. Med. J. (Engl). 2005, 118:1167-1174.
37. Subar, A.F., Krebs-Smith, S.M., Cook, A. and Kahle, L.L., Dietary sources of nutrients among US adults, 1989 to 1991. J .Am. Diet. Assoc. 1998, 98:537-547.
38. Tamura, T., Hong, K.H., Mizuno, Y., Johnston, K.E. and Keen, C.L., Folate and homocysteine metabolism in copper-deficient rats. Biochim.Biophys.Acta. 1999, 1427:351-356.
39. Tamura, T. and Turnlund, J.R., Effect of long-term, high-copper intake on the concentrations of plasma homocysteine and B vitamins in young men. Nutrition. 2004, 20:757-759.
40. Van Meurs, J.B., Dhonukshe-Rutten, R.A., Pluijm, S.M., Van der Klift, K.M., de Jonge, R., Lindemans, J., de Groot, L.C., Hofman, A., Witteman, J.C., van Leeuwen, J.P., Breteler, M.M., Lips, P., Pols, H.A. and Uitterlinden, A.G., Homocysteine levels and the risk of osteoporotic fracture. N. Engl. J. Med. 2004, 350:2033-2041.